Views Article – Sharenet Wealth

Europe, News

One-dose Sputnik V vaccine to have 73-85% efficacy – Russia fund chief

MOSCOW, Jan 14 (Reuters) – A one-dose course of Russia’s Sputnik vaccine against COVID-19 will have an efficacy rate of 73-85%, the head of the country’s sovereign wealth fund told Reuters on Thursday.

Authorities said on Monday that Russia would conduct a clinical trial of a one-dose version of its coronavirus vaccine, describing it as a possible “temporary” solution to help countries with high infection rates make the drug go further. (Reporting by Andrew Osborn and Polina Ivanova; writing by Tom Balmforth; editing by John Stonestreet)

© 2019 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.